Press release
Future Market Insights Forecasts Dengue Vaccines Market to Grow at 12.9% CAGR Through 2033, Expected to Reach US$ 1603.7 Million
Dengue Vaccines Market
Unlock the secrets of captivating visuals - claim your report. @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1763
Geographic Overview
Latin America is expected to remain the second largest market for dengue vaccines, with a valuation of nearly US$ 290 million by the end of the forecast period. The report also predicts that more pharmaceutical companies will become involved in the expansion of the dengue vaccine market in the near future.
According to the report, government institutes will continue to be the largest end-users of dengue vaccines. Dengue vaccine sales across government institutes will generate nearly US$650 million in revenue by the end of 2027. Furthermore, hospitals will maintain their dominance, with double-digit CAGRs throughout the forecast period. Sales of the sole vaccine, Dengvaxia, manufactured by Sanofi, are currently driving market growth. Furthermore, the factors influencing the market growth profiled in the report are discussed below.
Key Highlights of Dengue Vaccines Market Report
Other than the burdening occurrence of dengue in some countries, the economic turmoil in Latin America is estimated to influence the growth of the global market at the macroeconomic level.
Live attenuated vaccines are also produced and developed economically, thereby consoling the vaccine market and patients.
Low availability of optimum diagnostic systems and lack of skilled professionals have led to cases, where dengue fever is being treated as undistinguished febrile disease.
The global market of dengue vaccines is likely to secure an opportunistic revolution when companies are likely to able to successfully develop effective vaccines for all age groups.
Overall, the global dengue vaccines market, which is currently valued at nearly US$ 250 million, will increase rapidly to reach over US$ 1,250 million in terms of revenues, by the end of 2027.
According to FMI's report, the following dengue vaccine manufacturers operate within the global market landscape:
-Sanofi Pasteur Limited
-Takeda Pharmaceutical Company Limited
-Merck & Co. Inc.
-GlaxoSmithKline Plc.
-GeneOne Life Science Inc.
-Medigen Vaccine Biologics Corporation
-Panacea Biotec Limited
-Sun Pharmaceutical Industries Ltd
-Serum Institute of India Pvt. Ltd.
-Biological E Ltd.
Tap into Comprehensive Segmented Information - Purchase Today! @
https://www.futuremarketinsights.com/checkout/1763
Key Segments Covered
Product
-CYD-TDV (Dengvaxia)
End-User
-Hospitals
-Government Institutes
-Non-governmental Organizations (NGOs)
Region
-North America (US and Canada)
-Latin America (Brazil, Mexico, Venezuela and Rest of LATAM)
-Western Europe (Germany, UK, France, Spain, Italy and Rest of Western Europe)
-Eastern Europe (Russia, Poland and Rest of Eastern Europe)
-APEJ (The Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ)
-Japan
-Middle East & Africa (GCC, Northern Africa, South Africa and Rest of MEA)
>Have a Look at Trending Reports in the Healthcare Domain:
-Hadron Therapy Market: @ https://www.futuremarketinsights.com/reports/hadron-therapy-market
-Onychomycosis Treatment Market: @ https://www.futuremarketinsights.com/reports/onychomycosis-treatment-market
-Single-use Bioreactors Market: @ https://www.futuremarketinsights.com/reports/single-use-bioreactors-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Read The Complete Analysis Here: @
https://www.futuremarketinsights.com/reports/dengue-vaccines-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future Market Insights Forecasts Dengue Vaccines Market to Grow at 12.9% CAGR Through 2033, Expected to Reach US$ 1603.7 Million here
News-ID: 3187233 • Views: …
More Releases from Future Market Insights Inc.
Global Aerographite Market Outlook 2036: Growth, Regional Leaders & Key Players …
According to the latest analysis by Future Market Insights, the global aerographite market is entering a pivotal phase of industrial relevance, transitioning from niche nanomaterial curiosity to a commercially viable solution for weight-sensitive, high-performance applications. With aerospace OEMs, satellite integrators, and advanced energy system designers seeking materials that deliver structural strength without mass penalties, aerographite is emerging as a compelling answer. The convergence of scalable production methods and expanding end-use…
Global Textile-Based pH Controllers Market Set to Hit USD 2.50 Billion by 2036 | …
According to the latest analysis by Future Market Insights, in an industry where margins are tight and environmental scrutiny is rising, seemingly minor process variables are becoming boardroom priorities. One such variable-pH control in textile wet processing-is quietly reshaping operational efficiency, compliance strategies, and supplier dynamics. The global textile-based pH controllers market, once considered a niche within auxiliary chemicals, is now evolving into a critical enabler of quality assurance, cost…
Bio-Ceramics and Hydroxyapatite Market Enters a Clinical Expansion Phase as Inno …
According to the latest analysis by Future Market Insights, the global bio-ceramics and hydroxyapatite market is moving beyond its traditional role as a niche materials segment into a clinically strategic pillar of modern healthcare. With applications expanding from orthopaedic implants to regenerative medicine and drug delivery, the sector is entering a decade defined less by incremental demand and more by technological and regulatory inflection points. For executives and investors, the…
Bioethanol Market Enters Policy-Driven Expansion Cycle as Energy Security and De …
According to the latest analysis by Future Market Insights, the global bioethanol market is shifting from a cyclical, commodity-driven industry into a structurally supported pillar of national energy and climate strategies. What was once a blending option is now a compliance requirement. Governments across major economies are tightening renewable fuel mandates, and fuel distributors are responding by embedding bioethanol procurement into long-term supply strategies. This transition is reshaping capital allocation,…
More Releases for Dengue
Dengue Rapid Test Market To Witness Substantial Growth, 2026-2033| SD Biosensor …
The qualitative latest Research report (2026-2033) on the Dengue Rapid Test Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy (Complete TOC,…
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
